Clincosm LogoSign in Get a demo

Educational Intervention - Improving Knowledge and Screening Rates for Colorectal Cancer

Sponsor
Ohio State University Comprehensive Cancer Center (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT03287453
Collaborator
National Cancer Institute (NCI) (NIH)
200
Enrollment
1
Location
1
Arm
80.8
Anticipated Duration (Months)
2.5
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

This clinical trial studies how well educational intervention works in improving knowledge and screening rates of colorectal cancer. An educational intervention, such as viewing an inflatable colon, PowerPoint presentation, or flip books/flipcharts, may help improve knowledge about colorectal cancer and how often people get checked for colorectal cancers.

Condition or Disease Intervention/Treatment Phase
  • Other: Educational Intervention
  • Other: Survey Administration
 N/A

Detailed Description

PRIMARY OBJECTIVES:
  1. To increase colorectal cancer (CRC) knowledge, attitudes, positive behavior change, intent for screening, and screening among at-risk groups.
OUTLINE:

Participants attend educational sessions comprising of an inflatable colon interactive exhibit that allows visitors to walk through a colon while seeing images, or a PowerPoint presentation that contains messages that are tailored to meet the cultural and linguistic needs of Black/African Americans, Appalachians, and Hispanics/Latinos, and flip books/flip charts. Participants also receive a copy of the study information sheet which contains the basic elements of informed consent and a pre-education session knowledge survey.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
200 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Screen to Save Initiative
Actual Study Start Date :
Apr 8, 2017
Actual Primary Completion Date :
Sep 30, 2017
Anticipated Study Completion Date :
Dec 31, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Screening (educational intervention)

Participants attend educational sessions comprising of an inflatable colon interactive exhibit that allows visitors to walk through a colon while seeing images, a PowerPoint presentation that contains messages that are tailored to meet the cultural and linguistic needs of Black/African Americans, Appalachians, and Hispanics/Latinos, and or flip books/flip charts. Participants also receive a copy of the study information sheet which contains the basic elements of informed consent and a pre-education session knowledge survey.

Other: Educational Intervention
View an inflatable colon interactive exhibit, PowerPoint presentation, flip books, and flipcharts
Other Names:
  • Education for Intervention
  • Intervention by Education
  • Intervention through Education
  • Intervention, Educational

    • Other: Survey Administration
    Ancillary studies

    Outcome Measures

    Primary Outcome Measures

    1. Change in knowledge and degree to which reported intentions regarding colorectal cancer screening are related to the educational session [Up to two years]

      Change in knowledge will be examined as a function of the important covariates: race/ethnicity, sex, age, education and primary language. A paired t-test or Wilcoxon signed-rank test will be used to determine whether there is a statistically significant difference in pre and post session scores. The paired t-test provides a hypothesis test to determine whether pre and post session assessment mean scores differ from each other in a significant way under the assumptions that the paired differences are independent and identically normally distributed. The test statistic is t with n-1 degrees of f

    2. Change in knowledge and strength of intention to be screened [Up to two years]

      Will be correlated with key outcomes, specifically actual screening and actions promoting colorectal cancer screening (e.g., encouraging colorectal screening with family/friends). Multivariable logistic regression analyses will be conducted to examine the impact of knowledge change and strength of intentions on these binary outcomes (screened/not screened and encouraged/did not encourage colorectal screening) controlling for important covariates such as sex, race/ethnicity, age, education and primary language. A paired t-test or Wilcoxon signed-rank test will be used to determine whether there

    3. Frequency of reported family history of colorectal cancer [Up to two years]

      Will be described in total and as a function of specific racial/ethnic groups.

    4. Participants' plans for future screening [Up to two years]

      Will examine relationships between stated plans and key covariates.

    5. Reasons reported for not obtaining colorectal screening [Up to two years]

      Response categories will be examined by key covariates.

    6. Self-reported intentions to engage in behavior change to reduce risk of colorectal cancer [Up to two years]

      Will be examined by race/ethnicity, sex, education, and health insurance/healthcare coverage.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    50 Years to 74 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Participants from Franklin County or from Appalachia Ohio (depending on program location)

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Ohio State University Comprehensive Cancer Center Columbus Ohio United States 43210

    Sponsors and Collaborators

    • Ohio State University Comprehensive Cancer Center
    • National Cancer Institute (NCI)

    Investigators

    • Principal Investigator: Electra Paskett, PhD, Ohio State University Comprehensive Cancer Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Electra Paskett, Principal Investigator, Ohio State University Comprehensive Cancer Center
    ClinicalTrials.gov Identifier:
    NCT03287453
    Other Study ID Numbers:
    • OSU-17069
    • NCI-2017-01357
    • OSU-17069
    • P30CA016058
    First Posted:
    Sep 19, 2017
    Last Update Posted:
    May 11, 2022
    Last Verified:
    May 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:
    Colorectal Neoplasms

    Study Results

    No Results Posted as of May 11, 2022